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E. KRARUP, J. VESTBO, T. L. BENFIELD AND J. D. LUNDGREN 
Department of lnfecfious Diseases, Hvidovre Hospital, Denmark 
Human immunodeficiency virus (HIV)-infected patients are at increased risk of contracting bacterial 
infections, mainly pneumonia. Despite this, little is known about immunopathogenic mechanisms in 
HIV-related bacterial pneumonia. This paper investigates the presence of the neutrophil chemotactic 
mediators, interleukin-8 (IL-S) and leukotriene B4 (LTB,), in bronchoalveolar lavage (BAL) fluid from 
27 HIV-infected patients with bacterial pneumonia. Significantly elevated levels of IL-8 were found in 
BAL fluid of patients with bacterial pneumonia [529 pg ml - ’ (296-l 161 pg ml - I)] compared to matched 
patients with Pneumocystis carinii pneumonia (PCP) [59 pg ml - ’ (42-254 pg ml - ‘)] and healthy controls 
[58 pg ml- i (37~82pg ml - ‘)I. Levels of LTB, were not elevated during bacterial pneumonia when 
compared to PCP patients and healthy controls. Furthermore, a positive correlation was found between 
IL-8 levels in BAL Auid and relative BAL neutrophilia (rz0.60, P=O.OOl) in bacterial pneumonia. In 
conclusion, elevated IL-8 levels in BAL fluid were found in patients suffering from bacterial pneumonia, 
which may account for the influx of neutrophils to the lung, whereas LTB, appears not to be an 
important chemotactic factor in this setting. 
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Introduction 
Although infection with Pneumocystis carinii 
remains the most frequent cause of severe pul- 
monary disease in patients infected with human 
immunodeficiency virus (HIV), it has also been 
recognized that these patients are at increased 
risk for contracting bacterial pneumonia (14). 
Despite this, immunopathogenic mechanisms 
have received little attention. 
Increased levels of interleukin-8 (IL-S) in 
bronchoalveolar lavage (BAL) fluid have been 
reported in a number of pulmonary diseases 
characterized by neutrophil inflammation. These 
include bacterial pneumonia, adult respiratory 
distress syndrome (ARDS) (5,6), cystic fibrosis 
(7) and chronic inflammatory airway disease (8). 
Received 27 March 1996 and accepted in revised form 
25 July 1996. 
Correspondence should be addressed to: E. Krarup, 
Department of Microbiology, Bispebjerg Hospital, 
DK-2400 Copenhagen NV, Denmark. 
0954.6111/97/050317+05 $12.00/O 
Interestingly, a positive correlation between 
BAL levels of IL-8 and the total number of 
neutrophils in BAL fluid has been demonstrated 
in ARDS (9). 
HIV-infected patients are capable of initiating 
an IL-8 response to infection despite their gen- 
eral immune dysregulation. In AIDS-associated 
P. carinii pneumonia (PCP), the present authors 
have recently established a correlation between 
IL-8 levels, BAL neutrophilia and arterial oxy- 
gen tension (PaO,) (lo), and have demonstrated 
that elevated IL-8 levels confer a poor prognosis 
(11). Leukotriene B, (LTB,) is a potent mediator 
of neutrophil chemotaxis in vitro (12), and may 
play a role in the lung injury of bacterial pneu- 
monia in non-HIV patients (13). 
The authors’ hypothesis is that IL-8 and LTB, 
play a role in recruiting neutrophils in pulmo- 
nary disease. However, the beneficial effects of 
this response may also initiate and drive an 
inflammatory response, which may have detri- 
mental effects. 
(‘1 1997 W. B. SAUNDERS COMPANY LTD 
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To the authors’ knowledge, no reports have 
been published addressing levels of cytokines 
and neutrophilia in BAL fluid from HIV- 
positive patients with bacterial pneumonia. The 
aim of this study was to measure IL-8 and LTB, 
in BAL fluid, and study a possible correlation 
between these mediators and neutrophils in BAL 
fluid. 
Materials and Methods 
PATIENTS 
A total of 448 fibre-optic bronchoscopic pro- 
cedures were performed in 287 HIV-positive 
patients with pulmonary symptoms in the period 
from January 1989 to December 1993. Fifty- 
three of these patients had bacterial pneumonia, 
27 of whom had one sole pathogen identified 
both by microscopy and culture of BAL fluid. 
Clinical and laboratory data were collected pro- 
spectively. None of the patients had received 
treatment with corticosteroids. 
In order to compare possible differences in 
degree of pulmonary inflammation between 
HIV-infected patients suffering from bacterial 
and P. carinii pneumonia, 10 HIV-positive 
patients with P. carinii pneumonia were selected 
and matched for age, CD4 count and PaO, level. 
Ten medical students had bronchoscopy per- 
formed to act as healthy controls,. Informed 
consent was obtained from both $atients and 
volunteers. The study was conducted in accord- 
ance with the guidelines of the local Danish 
Ethics Committee. 
BRONCHOSCOPY 
Bronchoscopy was performed using local 
anesthaesia, as described previously (10). Briefly, 
60 ml aliquots of saline were instilled either in 
the right middle lobe (diffuse infiltrates) or at the 
site of localized infiltration. This was repeated 
up to a maximum of 300 ml. On average, 
6080% of the instilled volume was recovered. 
Bronchoalveolar lavage fluid was divided into 
samples for microbiology, pathology, cell differ- 
entials and cytokines (IL-8, LTB,). 
IL-8 AND LTB, ANALYSIS 
After centrifugation of BAL fluid, the super- 
natant was stored immediately at - 20°C. 
Analysis for IL-8 was done using a commercially 
available ELISA kit (Research & Diagnostic 
System, Minneapolis, U.S.A.). The manufac- 
turer’s protocol was followed. Minimal 
detectable amount of IL-8 was 18.6 pg ml - ‘. 
Undetectable levels were regarded as 0 pg ml - ‘, 
Analysis of levels of LTB, in BAL fluid was 
performed as described previously (10). Briefly, 
precipitation was done in 70% ethanol (16 h, 
YC), and after centrifugation, lipids were 
extracted over a C-18 Sep-pak column (Waters 
Associates, Milford, MA, U.S.A.). Extract was 
applied to a dual-pump, high-pressure, liquid 
chromatograph (HPLC, Beckman Instruments, 
Fullerton, CA, U.S.A.) with a Ultrasphere C,, 
reverse-phase column (Beckman), and the 
eicosanoids were separated. After collection of 
relevant fractions, lipids were extracted over a 
C- 18 Sep-pak column, and radioimmunoassy 
for LTB, was performed as recommended by 
the manufacturer (Advanced Magnetics, 
Cambridge, MA, U.S.A.). 
STATISTICS 
Results are expressed as median values and 95% 
confidence intervals (95% CI). Differences 
between groups were evaluated using the Mann- 
Whitney test. The Spearmann rho test was used 
to test for correlations between baseline values 
and mediators in the BAL fluid. PcO-05 was 
regarded as statistically significant. 
Results 
The most frequently isolated organisms were 
Streptococcus pneumoniae (12), Haemophilus 
influenzae (6) and Staphylococcus aureus (5). 
Less frequent were Branhamella catarrhalis (2), 
Klebsiella pneumoniae (1) and Acinetobacter (1). 
As shown in Table 1, no significant difference 
was found in PaO,, CD4 counts or IL-8 be- 
tween these groups. Eleven (40%) of the 
patients had received prophylactic treatment 
with either trimethoprim/sulphamethoxazole 
(three patients) or inhaled pentamidine (eight 
patients), and 10 patients received zidovudine 
when the pneumonia developed. 
Substantially elevated levels of IL-8 in BAL 
fluid were found in patients with bacterial 
pneumonia compared to healthy controls 
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Streptococcus pneumoniae 
Haemophilus inJluenzae 
Staphylococcus aweus 
Other bacteria 
Bacteria combined 
Pneumocystis carinii 
Control 
CD4 cell count IL-8 Neutrophil 
n (106 1-l) (Pg ml-‘) w> (i2) 
12 0.045 443.5 13 
(0~000-0~351) (186-1741) (l-95) (7.391:.2) 
6 0.001 121.5 
(26;4) 
10.2 
(0.000-0.096) (296-2423) (7811.4) 
5 0.060 972.0 26 11.0 
(0.016-0.162) (443-2003) (6-58) (7.3-12.7) 
4 0.013 269.5 
(0.000-0.432) (118-1984) (lY3) (6.79130-9) 
27 0.040 529 10.4 
(0.000-0.432) (296-l 161) (G5) (6.7-l 3.2) 
10 0.013 10.1 
(0~000-0~060) (42-754) (9.7-l 1.2) 
10 58.5 14.4 
(29-86) (l?,, (13.1-16.5) 
TABLE 1. Correlates of respiratory distress, death and inflammatory markers in human 
immunodeficiency virus (HIV)-positive patients with bacterial pneumonia or Pneumocystis 
carinii pneumonia (PCP) and healthy controls. 
Values are medians (95% CI). 
(P~0.05). As mentioned above and shown in 
Table 1, there was no significant difference in 
IL-8 in BAL fluid among different groups of 
patients with bacterial pneumonia. A positive 
correlation between the relative amount of neu- 
trophils and IL-8 in BAL fluid existed (v=O*60, 
P=O*OOl), as shown in Fig. 1. In contrast, 
levels of LTB, were the same in patients with 
bacterial pneumonia [21.7 pg ml - ’ (14.0- 
39.9 pg ml- ‘)I and healthy controls [22*6 pg 
ml-’ (18.7-32eOpg ml-‘), P=O*64]. 
This study found no statistically significant 
correlation between amount of neutrophils in 
BAL fluid and PaO, (rz0.35, n=25, P=O*O9). 
Ten patients with P. carinii were matched with 
pneumonia patients on age, CD4 count and 
PaO, in order to compare BAL IL-8 levels in 
these patients and patients with bacterial pneu- 
monia. Patients with bacterial pneumonia had 
significantly higher IL-8 levels compared to 
patients with PCP (529pg ml-’ (296-1161 pg 
ml-‘) vs. 57pg ml-’ (42-254pg ml-‘), 
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FIG. 1. Correlation between neutrophils and 
interleukin-8 (IL-8) in bronchoalveolar lavage 
(BAL) fluid in human immunodeficiency virus 
(HIV)-positive patients with bacterial pneumonia. 
rx0.596. 
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Discussion 
This study has identified IL-8 as a potential 
chemoattractant for neutrophils in HIV-infected 
patients with bacterial pneumonia. Interleukin-8 
levels were substantially higher than those found 
in HIV-infected patients suffering from PCP, 
and in healthy controls. Furthermore, the levels 
of IL-8 correlated with the percentage of neu- 
trophils in the BAL fluid. These findings agree 
with findings published previously in smaller 
series of patients (14). 
In this study, IL-8 levels in BAL fluid reached 
levels comparable with those found in immuno- 
competent patients suffering from bacterial 
pneumonia (5), regardless of the fact that the 
CD4 cell count was low and thus the specific 
immunological apparatus of the study patients 
was substantially compromised. This suggests 
that HIV-infected patients have an intact ability 
to recruit neutrophils independent of impair- 
ments in the immune function. 
Interleukin-8 levels in the HIV-infected 
patients with bacterial pneumonia were higher 
than IL-8 levels in matched patients with PCP; 
patients were matched for demographics and 
clinical severity (including PaO,). In PCP 
patients with more advanced respiratory impair- 
ment, IL-8 levels in BAL fluid are substantially 
higher (10,ll). 
It was found that in HIV-infected patients 
with bacterial pneumonia, the degree of inflam- 
mation failed to correlate with clinical severity, 
although the parameters tended to do so 
(r=0*35, P=O*O9). This is in contrast to previous 
studies of patients with bacterial pneumonia (5). 
Furthermore, IL-8 levels in BAL fluid may cor- 
relate with markers of clinical severity and may 
predict the prognosis in a variety of patient 
groups, e.g. HIV-infected patients suffering from 
PCP (IO, 1 l), and immunocompetent patients 
suffering from ARDS (1) and cystic fibrosis (7). 
In these situations, IL-8 is believed to cause 
impairment of the pulmonary function by caus- 
ing influx of neutrophils to the alveolar milieu. 
One possible explanation for these discrepancies 
may be that the advanced HIV infection from 
which most of the study patients were suffering 
allowed for a rapid multiplication of the bac- 
teria, and thus the quantum of bacteria in itself 
(and not the host reaction) was the primary 
factor in causing decreased arterial oxygen ten- 
sion. Further studies should be carried out to 
determine if the bacterial load in HIV-infected 
patients suffering from bacterial pneumonia is 
higher than what is seen in immunocompetent 
patients. 
The levels of LTB, in BAL fluid from patients 
suffering from bacterial pneumonia were not 
different from LTB, levels in PCP and in healthy 
controls. This agrees with previous findings in 
other patient categories (13). Thus, LTB, 
appears not to be an important chemotactic 
factor for the influx of neutrophils in the lung. 
Experimental studies have found that IL-8 is the 
primary chemotactic factor for neutrophils in the 
lungs (6,8,9,14,15). 
In conclusion, elevated levels of IL-8 were 
found in HIV-infected patients suffering from 
bacterial pneumonia, which presumably causes 
influx of neutrophils. The pathogenic mechanism 
allowing for the development of bacterial pneu- 
monia and which causes clinical symptoms 
should be further studied. 
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